텍사스의 전신경화증 임상 시험
전신경화증 관련 연구 12개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.
텍사스의 도시
공식 연구 텍스트(영어)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Tekton Research, Inc - West Gate Boulevard, Austin
- Arthritis & Rheumatology Institute - Frisco, Frisco
- The University of Texas Health Science Center at Houston, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07497087A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06195072A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
피험자 모집 중1/2상
18세 ~ 75세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Arlington, Arlington
- Artiva Investigational Site Bellaire, Bellaire
- Artiva Investigational Site Irving, Irving
- 외 4개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06991114A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT06827977Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
- UT Southwestern Medical Center - Department of Dermatology, Dallas
피험자 모집 중관찰 연구건강한 지원자 환영
90세 이하 · 모든 성별 · 2026. 5. 12. 업데이트됨 · NCT01808937Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT06434363A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 31. 업데이트됨 · NCT07047690Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
피험자 모집 중
18세 이상 · 모든 성별 · 2025. 6. 26. 업데이트됨 · NCT05989763Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 5. 7. 업데이트됨 · NCT05892614ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.